| Financial Year |
March 31 2023 |
| Monetary Funds |
275,651,810.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
798,759,710.40 |
| Advances to Suppliers |
11,822,503.45 |
| Other Receivables |
25,190,513.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
387,482,542.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,673,396.25 |
| Total Current Assets |
1,787,316,025.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,153,057.57 |
| Investment Properties |
-- |
| Fixed Assetes |
694,040,783.41 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
97,325,504.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,926,303.29 |
| Deferred Income Tax Assets |
72,313,616.91 |
| Other Non-Current Assets |
17,676,205.36 |
| Sub-Total of Non-Current Assets |
960,667,932.45 |
| Total Assets |
2,747,983,957.59 |
| Short-Term Loans |
221,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
110,580,000.00 |
| Accounts Payable |
111,029,860.87 |
| Accounts Received In Advance |
4,707,698.67 |
| Employee Compensation Payable |
13,705,385.67 |
| Taxes Payable |
18,362,991.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
257,549,109.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,351,734.60 |
| Sub-Total of Current Liabilities |
763,164,176.87 |
| Long-term Loans |
189,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,703,671.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
251,215,264.29 |
| Total Liabilities |
1,014,379,441.16 |
| Paid-In Capital(Or Share Stock) |
489,491,141.00 |
| Capital Surplus |
1,588,217,287.32 |
| Surplus Reserve |
29,615,319.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-401,380,945.66 |
| Minority Stockholder's Interest |
22,108,172.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,711,496,344.27 |
| Owner's Equity（Stockholder's Equity） |
1,733,604,516.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,747,983,957.59 |
